Belpointe Asset Management’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
25,569
-436
-2% -$35K 0.07% 263
2026
Q1
$1.97M Buy
26,005
+311
+1% +$24.3K 0.07% 245
2025
Q4
$1.92M Sell
25,694
-778
-3% -$58.1K 0.07% 232
2025
Q3
$1.95M Buy
26,472
+1,196
+5% +$85.8K 0.07% 225
2025
Q2
$1.79M Sell
25,276
-18
-0.1% -$1.2K 0.07% 220
2025
Q1
$1.61M Sell
25,294
-514
-2% -$32.2K 0.08% 223
2024
Q4
$1.51M Buy
25,808
+42
+0.2% +$2.62K 0.09% 223
2024
Q3
$1.7M Sell
25,766
-921
-3% -$59K 0.1% 196
2024
Q2
$1.67M Buy
26,687
+998
+4% +$62.4K 0.12% 172
2024
Q1
$1.61M Buy
25,689
+4,557
+22% +$272K 0.12% 162
2023
Q4
$1.23M Buy
+21,132
New +$1.18M 0.11% 185

Other funds holding JIRE

Belpointe Asset Management's JIRE Position: Q2 2026 in Review

Belpointe Asset Management reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 1.7% in Q2 2026, selling an estimated $35K and leaving 25,569 shares worth $2.11M. The position accounts for 0.07% of the portfolio, ranked #263.

Belpointe Asset Management first reported a position in JIRE in Q4 2023 and has held it in 11 quarters since. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Belpointe Asset Management held 25,569 shares of JPMorgan International Research Enhanced Equity ETF worth $2.11M as of Q2 2026.
  • Belpointe Asset Management sold 436 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $35K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.07% of Belpointe Asset Management's portfolio in Q2 2026, its #263 holding.
  • Belpointe Asset Management first reported a position in JPMorgan International Research Enhanced Equity ETF in Q4 2023 and has held it in 11 quarters since.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.